NCT02384876View on ClinicalTrials.gov

Determination of the Optimal Dose of Ephedrine in Intraoperative Arterial Hypotension of Newborns and Infants up to 6 Months of Age.

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 5, 2020

Study Completion Date

September 5, 2020

Conditions
Intraoperative Arterial HypotensionInfant, Newborn
Interventions
DRUG

Ephedrine 30mg/10mL injectable solution, single administration, dose : 0.6, 0.8, 1.0, 1.2 and 1.4 mg/kG

DRUG

Ephedrine 30mg/10mL injectable solution, single administration, dose : 0.1 mg/kG.

Trial Locations (3)

42055

Hôpital Nord, Saint-Etienne

63003

Hôpital d'Estaing, Clermont-Ferrand

Unknown

Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02384876 - Determination of the Optimal Dose of Ephedrine in Intraoperative Arterial Hypotension of Newborns and Infants up to 6 Months of Age. | Biotech Hunter | Biotech Hunter